2Saka M,Obata K,Ichihara S, et al. Pitavastatin improves cardiac function and survival in association with suppression of the myocardial endothelin system in a rat model of hypertensive heart fallure[J]. J Cardiovasc Pharmacol ,2006,47:770 -779.
3lehihara S, Noda A, Nagata K, et al. Pravastatin increases survival and suppresses and increase in myocardial matrix metalloproteinase activity in a rat model of heart failure[J]. Cardiovasc Res , 2006,69 : 726 - 735.
4Rauehhaus M, Clark AL, Doehner W, et al. The relationship between cholesterol and surviwl in patients with chronic heart failure [ J]. J Am Coll Cardiol ,2003,42 : 1933 - 1940.
5Rauchhaus M. Coats A J, Anker SD. The endotoxin - lipoprotein hypothesis[J]. Lancet ,2000,356:930 - 933.
6Rundek T,Naini A,Sacco R, et al. Atorvastafin decreases the coenzyme Q10 level in the blood of patients at risk for cardiovascular disease and stroke[J]. Arch Neurol ,2004,61:889 -892.
7Sola S,Mir MQ,Lerakis S, et al. Atorvastatin improves left ventricular systolic function and serum markers of inflammation in nonischemic heart failure[J]. JAm Goll Cardiol ,2006,47:332-337.
8Mozaffarian D,Minami E,Letterer RA, et al. The effects of atorvastatln(10mg) on systemic inflammation in heart failure[J]. Am J Cardiol ,2005,96 : 1699 - 1704.
9Mozaffarian D, Nye R, Levy W C. Statin therapy is associated with lower mortality among patients with severe heart failure[J]. Am J Cardiol ,2004,93 : 1124 - 1129.
10van der Harst P,Voors AA,van Gilst WH, et al. Statins in the treatment of chronic heart failure:a systematic review[ J]. PLoS Med ,2006,3 : e333.
1Silvestre J,Montoya M,Bruera E,et al.Intensive symptom control of opioid-refractory dyspnea in congestiveheart failure:Role of milrinone in the palliative care unit[J].Palliative&Supportive Care,2015,13(6):1781-1785.
2Pareek A,Chandurkar N,Thulaseedharan N K,et al.Efficacy and safety of fixed dose combination of atorvastatin and hydroxychloroquine:a randomized,double-blind comparison with atorvastatin alone among Indian patients with dyslipidemia[J].Current Medical Research and Opinion,2015,31(11):2105-2117.
3Dokainish H,Teo K,Zhu J,et al.Heart failure in low-and middle-income countries:background,rationale,and design of the International Congestive Heart Failure Study(INTERCHF)[J].American Heart Journal,2015,170(4):627-634.
4Tani S,Takahashi A,Nagao K,et al.Contribution of apolipoprotein A-I to the reduction in high-sensitivity C-reactive protein levels by different statins:comparative study of pitavastatin and atorvastatin[J].Heart and Vessels,2015,30(6):762-770.
5Potey C,Ouk T,Petrault O,et al.Early treatment with atorvastatin exerts parenchymal and vascular protective effects in experimental cerebral ischaemia[J].British Journal of Pharmacology,2015,172(21):5188-5198.
